Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

Comprehensive treatment based on chemotherapy is regarded as the first-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). However, chemoresistance is common among patients with ESCC. Therefore, there is a need to explore new therapeutic strategies...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: DANG, LIFENG, WEN, FENGBIAO, YANG, YANG, LIU, DONGLEI, WU, KAI, QI, YU, LI, XIANGNAN, ZHAO, JIA, ZHU, DENGYAN, ZHANG, CHUNYANG, ZHAO, SONG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2014
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020493/
https://ncbi.nlm.nih.gov/pubmed/24584782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2014.1678
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak